title: Response.
authors.affiliation: Endocrine Hypertension Research Centre and Clinical Centre of Research Excellence in Cardiovascular Disease and Metabolic Disorders, The School of Medicine, The University of Queensland, Princess Alexandra and Greenslopes Private Hospitals, Brisbane, QLD, Australia; Dante Pazzanese Institute of Cardiology, São Paulo, Brazil; Sleep/Wake Disorders Center, The University of Alabama at Birmingham, Birmingham, AL.
authors.forename: Eduardo
authors.initials: E
authors.lastname: Pimenta
authors.affiliation: Division of Pulmonary, Allergy and Critical Care Medicine, and Vascular Biology and Hypertension Program, The University of Alabama at Birmingham, Birmingham, AL. Electronic address: dcalhoun@uab.edu.
authors.forename: David A
authors.initials: DA
authors.lastname: Calhoun
mesh_terms: D005260:Female; D006801:Humans; D006929:Hyperaldosteronism / Q000453:epidemiology*; D006973:Hypertension / Q000453:epidemiology*; D008297:Male; D012720:Severity of Illness Index; D020181:Sleep Apnea, Obstructive / Q000175:diagnosis* / Q000453:epidemiology*; D012982:Sodium, Dietary / Q000009:adverse effects*
chemical_list: D012982:Sodium, Dietary
references.citation: Am J Physiol Heart Circ Physiol. 2002 Nov;283(5):H1802-10
references.pmid: 12384457
references.citation: J Lab Clin Med. 1992 Dec;120(6):893-901
references.pmid: 1453111
references.citation: J Hum Hypertens. 2010 Aug;24(8):532-7
references.pmid: 20016520
references.citation: Chest. 2013 Apr;143(4):978-983
references.pmid: 23288434